Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern

por Gao, Steven Y., Amaro-Mugridge, Nancy B., Madrid-Weiss, Jocelyn, Petkovic, Nikolina, Vanegas, Natasha, Visvanathan, Kumar, Williams, Bryan R. G., MacDiarmid, Jennifer A., Brahmbhatt, Himanshu
Publicado 2023